Evidence map›Paper›PMID 38659894›Full record

ArticlebioRxiv : the preprint server for biology2024

Machine learning methods for predicting guide RNA effects in CRISPR epigenome editing experiments.

Wancen Mu, Tianyou Luo, Alejandro Barrera, Lexi R Bounds, Tyler S Klann, Maria Ter Weele, Julien Bryois, Gregory E Crawford, Patrick F Sullivan, Charles A Gersbach and 2 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Wancen MuDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-5061-7581
Tianyou LuoDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Alejandro BarreraCenter for Genomic and Computational Biology, Duke University, Durham, NC, USA.
Lexi R BoundsCenter for Advanced Genomic Technologies, Duke University, Durham, NC, USA.
Tyler S KlannCenter for Genomic and Computational Biology, Duke University, Durham, NC, USA.
Maria Ter WeeleCenter for Advanced Genomic Technologies, Duke University, Durham, NC, USA.
Julien BryoisDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Gregory E CrawfordCenter for Genomic and Computational Biology, Duke University, Durham, NC, USA.
Patrick F SullivanDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Charles A GersbachCenter for Genomic and Computational Biology, Duke University, Durham, NC, USA.
Michael I LoveDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Yun LiDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Duke University · USUniversity of North Carolina at Chapel Hill · US

Funding

The Duke FUNCTION Center: Pioneering the comprehensive identification of combinatorial noncoding causes of diseaseRM1HG011123 · NHGRI · DUKE UNIVERSITY · PI GREGORY E CRAWFORD, Raluca Gordan · 2020 to 2026
$21.9M
High-Throughput Functional Annotation of Gene Regulatory Elements and Variants Critical to Complex Cellular PhenotypesUM1HG012053 · NHGRI · DUKE UNIVERSITY · PI GREGORY E CRAWFORD, Charles A. Gersbach · 2021 to 2026
$10.7M
University Training Program in Biomolecular & Tissue EngineeringT32GM008555 · NIGMS · DUKE UNIVERSITY · PI GERSBACH, CHARLES A. · 1994 to 2021
$8.1M
Beyond GWAS: High Throughput Functional Genomics & Epigenome Editing to Elucidate the Effects of Genetic Associations for SchizophreniaR01MH125236 · NIMH · DUKE UNIVERSITY · PI CRAWFORD, GREGORY E, GERSBACH, CHARLES A. · 2021 to 2025
$8.1M
Regulatory Mechanisms of CD4+ T Cell DifferentiationUM1HG009428 · NHGRI · DUKE UNIVERSITY · PI CIOFANI, MARIA, CRAWFORD, GREGORY E · 2017 to 2021
$4.6M
Quantifying the genetic diversity of human regulatory element activityR01HG010741 · NHGRI · DUKE UNIVERSITY · PI ALLEN, ANDREW S, CRAWFORD, GREGORY E · 2019 to 2022
$3.1M
A Modular Framework for Accurate, Interpretable, and Reproducible Analysis of Long Read RNA-Seq DataR01HG009937 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Michael Isaiah Love, Robert Patro · 2018 to 2026
$2.8M
University Training Program in Biomolecular and Tissue EngineeringT32GM144291 · NIGMS · DUKE UNIVERSITY · PI Charles A. Gersbach, Tatiana Segura · 2022 to 2026
$2.6M
NHGRI NIH HHS R01 HG009937NHGRI NIH HHS R01 HG010741NHGRI NIH HHS RM1 HG011123NHGRI NIH HHS UM1 HG009428NHGRI NIH HHS UM1 HG012053NIGMS NIH HHS T32 GM008555NIGMS NIH HHS T32 GM144291NIMH NIH HHS R01 MH125236
6 · The paper itself

Abstract

CRISPR epigenomic editing technologies enable functional interrogation of non-coding elements. However, current computational methods for guide RNA (gRNA) design do not effectively predict the power potential, molecular and cellular impact to optimize for efficient gRNAs, which are crucial for successful applications of these technologies. We present "launch-dCas9" (machine LeArning based UNified CompreHensive framework for CRISPR-dCas9) to predict gRNA impact from multiple perspectives, including cell fitness, wildtype abundance (gauging power potential), and gene expression in single cells. Our launchdCas9, built and evaluated using experiments involving >1 million gRNAs targeted across the human genome, demonstrates relatively high prediction accuracy (AUC up to 0.81) and generalizes across cell lines. Method-prioritized top gRNA(s) are 4.6-fold more likely to exert effects, compared to other gRNAs in the same cis-regulatory region. Furthermore, launchdCas9 identifies the most critical sequence-related features and functional annotations from >40 features considered. Our results establish launch-dCas9 as a promising approach to design gRNAs for CRISPR epigenomic experiments.

Indexed as

cis-regulatory elementsdeep learningpertubation experiemnts

Identifiers

PMID38659894
PMCPMC11042384
OpenAlexW4394979056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.